(Q61957032)
Statements
Phase I, Randomized, Double-Blind, Placebo Controlled, Dose Escalation,Single Dose, Safety, Tolerance, and Pharmacokinetic Study of CXB909 in Healthy Male Volunteers (English)
0 references
December 2012
0 references
December 2013
0 references
40
0 references
18 year
0 references
50 year
0 references